Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1990-1-23
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1046-9516
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
92
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
21-42
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2512493-Drug Evaluation,
pubmed-meshheading:2512493-Drug and Narcotic Control,
pubmed-meshheading:2512493-Humans,
pubmed-meshheading:2512493-Methaqualone,
pubmed-meshheading:2512493-Street Drugs,
pubmed-meshheading:2512493-Substance-Related Disorders,
pubmed-meshheading:2512493-United States
|
pubmed:year |
1989
|
pubmed:articleTitle |
The role of abuse liability testing in drug control procedures.
|
pubmed:affiliation |
Drug Control Section, Office of Diversion Control, Drug Enforcement Administration, Washington, D.C. 20537.
|
pubmed:publicationType |
Journal Article
|